according to komonews
6-year-old boy dies of rare mystery disease spreading in Wash. state
6-year-old boy dies of rare mystery disease spreading in Wash. stateMORE MEDIA Mystery illnessSEATTLE - A mysterious illness that hospitalized several local children has now turned deadly.A 6-year-old boy who has been treated for the disease for more than two weeks passed away Sunday night.The boy, 6-year-old Daniel Ramirez of Bellingham, was one of eight children being treated at Seattle Children's Hospital for a disease that has baffled medical staff.KOMO News spoke to Daniel's parents on Friday, and they said he was sent to the hospital with cold symptoms and dizziness.
in the same way fiercebiotech
Q3 clearout: Shire dumps rare disease med, Gilead cuts simtuzumab
Q3 clearout: Shire dumps rare disease med, Gilead cuts simtuzumabIt's that time of year when biopharmas sneak out negative R&D news amid a swath of financial data, and the FierceBiotech team has delved deep into the reports and found out which programs have been quietly dumped.Pfizer's ($PFE) shock announcement that it was killing off all development for its PCSK9 candidate grabbed the headlines this week, but both Shire ($SHPG) and Gilead ($GILD) have also terminated some potentially big programs.First up, to Gilead.Just two weeks ago, it posted some mixed data for its experimental med GS-4997 (a.k.a.
let alone bellinghamherald
9th child in Washington may have rare neurological disease
9th child in Washington may have rare neurological disease1:07 Firefighters tackle house fire south of Bellingham Pause2:55 DEA warns police and public: Fentanyl exposure can kill you1:44 Bellingham woman creates 'Nasty Woman' T-shirt1:11 Squalcum football looking for big things in 20163:25 What's in store for the U.S. this winter?0:31 How to check your ballot status0:47 Watch Bellingham's Annika Reiss win the NWC girls title0:53 Check out the vertigo-inducing view from the Sky Pilot suspension bridge in Squamish1:19 Tacoma students reassemble whale skeleton
No comments:
Post a Comment